CPRX vs EXC · P/E 18, rev $491.7M vs P/E 17, rev $24.26B
Catalyst Pharmaceuticals Inc (CPRX) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the CPRX and EXC stock pages for the full models.
Not investment advice.